Restrictive cardiomyopathy is a form of cardiomyopathy in which the walls are rigid, and the heart is restricted from stretching and filling with blood properly. It is the least common of Goodwin's three original subtypes of cardiomyopathy, which includes hypertrophic and dilated as well as restrictive. It should not be confused with constrictive pericarditis, a disease which presents similarly but is very different in treatment and prognosis.
Presentation Rhythmicity and contractility of the heart may be normal, but the stiff walls of the heart chambers keep them from adequately filling, reducing preload and end-diastolic volume. Thus, blood flow is reduced, and blood volume that would normally enter the heart is backed up in the circulatory system. In time, restrictive cardiomyopathy patients develop diastolic dysfunction and eventually heart failure. Untreated hearts with RCM often develop the following characteristics: Biatrial enlargement, thickened LV walls, thickened RV free wall, elevated right atrial pressure, moderate pulmonary hypertension, normal systolic function, poor diastolic function, typically Grade III - IV Diastolic heart failure. Causes It is possible to divide the causes into primary and secondary. = Primary = Löffler's endocarditis endocardial fibroelastosis = Secondary = infiltrative cardiac amyloidosis haemochromatosis sarcoidosis interstitial postradiation fibrosis Other causes include scleroderma, Churg-Strauss syndrome, cystinosis, lymphoma, Gaucher's disease, Fabry's disease, pseudoxanthoma elasticum, hypereosinophilic syndrome, carcinoid, Noonan's syndrome, reactive arthritis, and Werner's syndrome. Treatment Treatment of restrictive cardiomyopathy should focus on management of causative conditions, and slowing the progression of cardiomyopathy. Diuretics, vasodilators, angiotensin-converting enzyme inhibitors, and anticoagulation may be indicated for managing restrictive cardiomyopathy.
Calcium channel blockers are generally contraindicated due to their negative inotropic effect, particularly in cardiomyopathy caused by amyloidosis. Digoxin, calcium channel blocking drugs and beta-adrenergic blocking agents provide little benefit, except in the subgroup of restrictive cardiomyopathy with atrial fibrillation. Heart failure resulting from restrictive cardiomyopathy will usually eventually have to be treated by cardiac transplantation or left ventricular assist device. References External links Overview at Merck Manual.
Coenzyme Q10 and Hawthorn For Heart Health and Blood Pressure By Dr. James Meschino, DC, MS, ND Let me introduce you to two really important anti-aging disease prevention nutrients.…Views: 47 083 By: Dr.James Meschino
What if we told you, you can compare the most affordable treatments worldwide? Yes! Placidway is a leading medical tourism company that helps you explore global healthcare solutions…Views: 1 221 By: PlacidWay Medical Tourism
In our Mitral Foundation Video Teaching Library we are going to show a series of cases that demonstrate teaching points in the field of mitral valve reconstruction. In today's video,…Views: 4 481 By: Mitral Foundation
Well, Miss Haines had a problem with hepatitis -- hepatitis C. It damaged her liver, but also there was a cardiomyopathy that made her liver fail. Her heart failure also made her liver…Views: 433 By: HenryFordTV
(Music) Hi, I'm Cora. I'm Dr. Jaudy's patient. I came... To look for him, but I became, like, an accidental patient through my son, but seeing how he's treating my son,…Views: 90 By: Dr. Gilbert Jaudy
Hi I'm D. Diane Cleverley, Personal Healthcare Information. Welcome to this episode of Silent Killers. This week we're going to talk about Heart Attacks. If you've been…Views: 525 By: Personal Healthcare Information